| Literature DB >> 12871362 |
V J Cole1, J M Staton, J W Eikelboom, G J Hankey, Q Yi, Y Shen, M C Berndt, R I Baker.
Abstract
Several polymorphisms of integrin alpha2beta1 and glycoprotein (GP) VI that may modify platelet-collagen interactions or subsequent signaling have been described. We conducted a case-control study involving 180 stroke patients and 172 controls to determine whether the alpha2 C807T and GPVI Q317L polymorphisms were associated with an increased risk of ischemic stroke. We found no statistically significant differences in the distribution of alpha2 C807T and GPVI Q317L in patients and controls overall or after stratification by etiological subtype. The GPVI 317QQ genotype was found to be over-represented in a subgroup of patients >/=60 years compared to corresponding controls. However, this association did not remain significant after adjustment for other cardiovascular risk factors. Our results do not support a role for the integrin alpha2 C807T and GPVI Q317L polymorphisms in the development of first-ever ischemic stroke. However, larger studies are required to confirm this.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12871362 DOI： 10.1046/j.1538-7836.2003.00179.x
Source DB: PubMed Journal: J Thromb Haemost ISSN： 1538-7836 Impact factor: 5.824